Co-Authors
This is a "connection" page, showing publications co-authored by Dong Liang and Yang Wang.
Connection Strength
2.864
-
Wang Y, Xie H, Ma J, Du T, Gao S, Chen Y, Lin SY, Liang D. Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer. Pharmaceutics. 2025 Aug 13; 17(8).
Score: 0.961
-
Wang Y, Ma J, Lin SY, Xie H, Liang D. A stability indicating LC-MS/MS method for quantification of a NOX Inhibitor R14 in its bisulfite adduct form for pharmacokinetic studies. J Pharm Biomed Anal. 2023 May 10; 228:115326.
Score: 0.812
-
Wang Y, Xie H, Alugubelli YR, Ma Y, Xu S, Ma J, Liu WR, Liang D. Accurate Mass Identification of an Interfering Water Adduct and Strategies in Development and Validation of an LC-MS/MS Method for Quantification of MPI8, a Potent SARS-CoV-2 Main Protease Inhibitor, in Rat Plasma in Pharmacokinetic Studies. Pharmaceuticals (Basel). 2022 May 27; 15(6).
Score: 0.769
-
Wang Y, Ma J, Martinez ED, Liang D, Xie H. A UHPLC-MS/MS method for the quantification of JIB-04 in rat plasma: Development, validation and application to pharmacokinetics study. J Pharm Biomed Anal. 2020 Nov 30; 191:113587.
Score: 0.170
-
Du T, Wang Y, Xie H, Liang D, Gao S. Fragmentation Patterns of Phenolic C-Glycosides in Mass Spectrometry Analysis. Molecules. 2024 Jun 21; 29(13).
Score: 0.056
-
Sarkar M, Wang Y, Ekpenyong O, Liang D, Xie H. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 03; 15(2):e1846.
Score: 0.049
-
Gao X, Tsai RYL, Ma J, Wang Y, Liu X, Liang D, Xie H. Determination of Oxaliplatin by a UHPLC-MS/MS Method: Application to Pharmacokinetics and Tongue Tissue Distribution Studies in Rats. Pharmaceuticals (Basel). 2021 Dec 31; 15(1).
Score: 0.047